期刊文献+

复发性脑梗死合并高血压患者使用降压药情况的调查 被引量:1

Investigation of Antihypertensive Drugs in Patients with Recurrent Cerebral Infarction Complicated with Hypertension
下载PDF
导出
摘要 目的分析复发性脑梗死合并高血压患者使用降压药情况。方法选取120例于2013年8月—2014年8月期间该院接收的复发性脑梗死合并高血压患者,均填写问卷调查表,观察用药情况及分析用药不规范的原因。结果 120例复发性脑梗死合并高血患者住院期间均接收降压治疗,其中78例(65.0%)出院后降压药依从性差,其中43例(35.83%)可坚持服用降压药,但常自行更改剂量和药物种类;25例(20.83%)患者间断服用降压药,10例(8.3%)未服用降压药物,引起78例不规范用药的原因有不良反应、认识不足、药物较多、用药缺乏监督等。结论脑梗死合并高血压患者降压药使用不规范的比例较大,降压达标率较低,应针对服药不规范的原因给予相应的健康教育,以提高依从性。 Objective Analysis of recurrent cerebral infarction using medications in patients with hypertension. Methods Select 120 cases in August 2013 to August 2014 during our receive recurrent cerebral infarction in patients with hypertension, fill in the questionnaire, observation of drug utilization and the reasons for the analysis of drug use is not standard.Results 120 patients with recurrent cerebral infarction combined high blood during hospitalization were receiving treatment,78 cases(65.0%) after discharge blood pressure medication adherence is poor, 43 cases(35.83%) can insist on taking blood pressure medication, but often to change the dose and drug category; 25 cases(20.83%) patients stopped taking blood pressure medication, 10 cases(8.3%) is not taking antihypertensive drugs, the causes of 78 cases of non-standard drug adverse reactions, inadequate understanding, lack of supervision and more drugs, medication, other. Conclusion Cerebral infarction with hypertension antihypertensive drug use non-standard larger proportion, step-down success rate is low, should be aimed at the cause of the medicine is not standard give corresponding health education, in order to improve the compliance.
作者 苗玉敏
出处 《中国卫生产业》 2015年第31期158-159,共2页 China Health Industry
关键词 脑梗死 高血压 复发性脑梗死 Cerebral infarction High blood pressure Recurrent cerebral infarction
  • 相关文献

参考文献6

二级参考文献46

  • 1刘国树.钙离子通道阻滞剂治疗高血压病新进展[J].中国药物应用与监测,2006,3(4):1-4. 被引量:10
  • 2宋志芳,郑泽琪,谢富兰.氯沙坦和拜心同联合治疗对高血压病患者肾功能的影响[J].江西医学院学报,2004,44(6):53-55. 被引量:6
  • 3吕伟伟,董玉波,孙成春,孙军.利用PASS系统监测医嘱用药[J].中国药房,2005,16(22):1708-1709. 被引量:28
  • 4Qin XH, Li JP, Cui YM, et al. MTHFR C677T and MTR A2756G polymorphisms and the homocysteine lowering efficacy of different doses of folic acid in hypertensive Chinese adults [J]. Nutrition Journal, 2012, 11: 2-8.
  • 5Mao GY, Hong XM,Xing HX,et al. Efficacy of folic acid and enalapril combined therapy on reduction of blood pressure and plasma glucose: A multicenter, randomized, double-blind, paral- lel-controlled, clinical trial [J]. Nutrition, 2008, 24:1 088-1 096.
  • 6Agostino Virdis,Marc Iglarz,Mario Fritsch Neves, et al. Effect of hyperhomoeystinemia and hypertension on Endothelial func- tion in methylenetetrahydrofolate reductase-deficient mice[J]. Arterioscler Thromb Vasc Biol,2003,23:1 352-1 357.
  • 7Hillen T,Coshall C,TiUing al. For the South London StrokeRegister. Cause of stroke recurrence is multifactorial : Patterns, riskfactors,and outcomes of stroke recurrence in the South LondonStroke Register[J]. Stroke,2003,34(6) : 1457 - 1463.
  • 8Kissela BM,Khoury J,Kleindorfer D,et al. Epidemiology of ische-mic stroke in patients with diabetes:The greater Cincinnati/North-ern Kentucky Stroke Study[J]. Diabetes Care, 2005,28 (2) : 355 -359.
  • 9Ivey FM, Ryan AS, Hafer - Macko CE,et al. High prevalence ofabnormal glucose metabolism and poor sensitivity of fasting plas-ma glucose in the chronic phase of stroke [J], Cerebrovasc Dis,2006,22:368 -371.
  • 10Kothari V,Stevens RJ,Adler AL,et al, UKPDS 60: Risk of strokein type 2 diabets estimated by the UK Prospective Diabetes Studyrisk enging[J]. Storke,2002 ,33(7) : 1776 - 1781.

共引文献25

同被引文献16

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部